Skip to main content

Noninvasive Ventilation

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Utah Medical
Utah MedicalIreland - Dublin
1 program
Noninvasive Ventilation Mask MicrophoneN/A1 trial
Active Trials
NCT04912544Completed10Est. May 2022
Convergent Therapeutics
1 program
Oro-nasal MaskN/A1 trial
Active Trials
NCT02383719Completed18Est. Jan 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Utah MedicalNoninvasive Ventilation Mask Microphone
Convergent TherapeuticsOro-nasal Mask

Clinical Trials (2)

Total enrollment: 28 patients across 2 trials

NCT04912544Utah MedicalNoninvasive Ventilation Mask Microphone

Facilitating Patient Communication During Noninvasive Ventilation

Start: Oct 2021Est. completion: May 202210 patients
N/ACompleted

A Feasibility Study Evaluating the Use of a Non-invasive Ventilation Mask

Start: Mar 2015Est. completion: Jan 201618 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.